The $42 Billion Drug? Why AbbVie May Have Overpaid for Pharmacyclics - Wall Street wonders if AbbVie overpaid for Pharmacyclics.
37 minutes ago
Addressing threats to health care's core values, especially those stemming from concentration and abuse of power. Advocating for accountability, integrity, transparency, honesty and ethics in leadership and governance of health care.